Search
for

    Sort by

    Research 181–210 of 1000+

    1. FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women Online journal of complementary & alternative medicine · 2020
    2. Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir Annals Academy of Medicine Singapore · 2022 · 5 citations
    3. Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports Phytotherapy Research · 2023 · 2 citations
    4. Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health Pharmaceuticals · 2025 · 4 citations
    5. Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III Cardiology in Review · 2002 · 15 citations
    6. Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications Nutrients · 2026
    7. 705 Influence of 5a-Reductase Inhibitor (5-ARI) Usage on the Reproductive Function of Married Men The Journal of Sexual Medicine · 2018
    8. A review of the treatment of male pattern hair loss Expert Opinion on Pharmacotherapy · 2020 · 53 citations
    9. Current Literature Review The Journal of Sexual Medicine · 2013
    10. The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study Cureus · 2025
    11. Post-finasteride syndrome Anais Brasileiros De Dermatologia · 2020 · 15 citations
    12. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    13. An (Ir)reversible Affection of the Sexual Sphere: A Case Report Journal of Psychosexual Health · 2026
    14. Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review JMIR Dermatology · 2025
    15. Digital health platforms expand access and improve care for male androgenetic alopecia International Journal of Dermatology · 2022
    16. The connection of 5-alpha reductase inhibitors to the development of depression Biomedicine & Pharmacotherapy · 2021 · 4 citations
    17. Battling a receding tide: Treatment for androgenic alopecia Australian Journal of General Practice · 2025
    18. Biomaterials for Treatment of Baldness Cureus · 2022
    19. A Gender Hypothesis of sex disparities in adverse drug events Social Science & Medicine · 2023 · 8 citations
    20. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity European Journal of Endocrinology · 2020 · 175 citations
    21. Direct-to-consumer pharmaceutical services in dermatology: Ethical implications Journal of The American Academy of Dermatology · 2021 · 5 citations
    22. Spironolactone Elsevier eBooks · 2015
    23. An Update on Hair Restoration Journal of Aesthetic & Reconstructive Surgery · 2015 · 1 citations
    24. Post-finasteride syndrome: An emerging clinical problem Neurobiology of Stress · 2019 · 26 citations
    25. A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection The Milbank Quarterly · 2006 · 108 citations
    26. Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism Southern Medical Journal · 2010 · 46 citations
    27. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia Translational Andrology and Urology · 2020 · 7 citations
    28. Chronic telogen effluvium in a man Journal of The American Academy of Dermatology · 2002 · 10 citations
    29. Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness? Skin appendage disorders · 2019 · 14 citations
    30. Post-finasteride syndrome – does it really exist? The Aging Male · 2019 · 7 citations